1-4 of 4
Susanne Viebahn
Close
Sort by
Journal Articles

Siglec-7 Tetramers Characterize B Cell Subpopulations and Identify Immunomodulatory Ligands on Malignant Cells

Philippa Mang, Friederike Gieseke, PhD, Susanne Viebahn, PhD, Inga Gondesen, Anne Kruchen, Annika Erbacher, PhD, Matthias Pfeiffer, MD, Rupert Handgretinger, MD, PhD, Ingo Müller, MD
Journal: Blood
Blood (2010) 116 (21): 1728.
https://doi.org/10.1182/blood.V116.21.1728.1728
Published: 2010
Journal Articles

Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNγR1 signaling and IDO expression

Brief Report
Friederike Gieseke, Burkhardt Schütt, Susanne Viebahn, Ewa Koscielniak, Wilhelm Friedrich, Rupert Handgretinger, Ingo Müller
Journal: Blood
Blood (2007) 110 (6): 2197–2200.
https://doi.org/10.1182/blood-2007-04-083162
Published: 2007
Journal Articles

Human Multipotent Mesenchymal Stromal Cells Inhibit Proliferation of PBMC in the Absence of Functional IFNγR1 and IDO Expression.

Friederike Gieseke, MS, Susanne Viebahn, MS, Sandra Kordowich, MS, Ewa Koscielniak, MD, Wilhelm Friedrich, MD, Rupert Handgretinger, MD, Ingo Müller, MD
Journal: Blood
Blood (2006) 108 (11): 2567.
https://doi.org/10.1182/blood.V108.11.2567.2567
Published: 2006
Journal Articles

Pediatric T-ALL but Not cALL Blasts Express Ligands for Siglec-7 Inhibiting NK Cell Mediated Lysis.

Susanne Viebahn, MS, Friederike Gieseke, MS, Matthias Pfeiffer, MS, Rupert Handgretinger, MD, Ingo Müller, MD
Journal: Blood
Blood (2006) 108 (11): 1844.
https://doi.org/10.1182/blood.V108.11.1844.1844
Published: 2006